CPT code 0970T represents percutaneous laser ablation of benign breast tumors, such as fibroadenomas, using laser energy with image guidance. This minimally invasive, tissue-destructive procedure offers an alternative to surgical excision for selected patients and has implications for outpatient surgical practice patterns, device utilization, and payer coverage policies nationally. The code captures a specific, technology-driven procedure that can affect site-of-service decisions and resource use for breast lesion management.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical settings where the service is delivered, and the common modifiers associated with this code. The publication summarizes billing and coding considerations, benchmarks for utilization where available, and policy and coverage themes that influence access and reimbursement for image-guided breast tumor ablation.

This analysis helps clinicians, billing professionals, and policy stakeholders understand the procedural definition, typical use cases, and payer landscape relevant to CPT code 0970T. Data not available in the input are clearly noted where applicable.